Progression of axonal excitability abnormalities with increasing clinical severity of diabetic peripheral neuropathy
Open Access
- 9 February 2024
- journal article
- research article
- Published by Elsevier in Clinical Neurophysiology
- Vol. 160, 12-18
Abstract
No abstract availableKeywords
Funding Information
- Johns Hopkins University
- University of New South Wales
This publication has 56 references indexed in Scilit:
- Axonal Excitability Does Not Differ between Painful and Painless Diabetic or Chemotherapy‐Induced Distal Symmetrical Polyneuropathy in a Multicenter Observational StudyAnnals of Neurology, 2022
- Fampridine treatment and walking distance in multiple sclerosis: A randomised controlled trialClinical Neurophysiology, 2017
- Effect of fampridine on axonal excitability in multiple sclerosisClinical Neurophysiology, 2016
- In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetesClinical Neurophysiology, 2016
- Mechanisms of axonal dysfunction in diabetic and uraemic neuropathiesClinical Neurophysiology, 2013
- Altered expression and function of sodium channels in large DRG neurons and myelinated A-fibers in early diabetic neuropathy in the ratBiochemical and Biophysical Research Communications, 2006
- Changes of sodium channel expression in experimental painful diabetic neuropathyAnnals of Neurology, 2002
- Threshold tracking techniques in the study of human peripheral nerveMuscle & Nerve, 1998
- Abnormal axonal inward rectification in diabetic neuropathyMuscle & Nerve, 1996
- Reversible and irreversible nodal dysfunction in diabetic neuropathyAnnals of Neurology, 1987